NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer.
Yotsumoto T, Maemura K, Watanabe K, Amano Y, Matsumoto Y, Zokumasu K, Ando T, Kawakami M, Kage H, Nakajima J, Yatomi Y, Nagase T, Takai D.
Yotsumoto T, et al. Among authors: kawakami m.
Oncotarget. 2020 Sep 29;11(39):3590-3600. doi: 10.18632/oncotarget.27718. eCollection 2020 Sep 29.
Oncotarget. 2020.
PMID: 33062195
Free PMC article.